Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03595891
Other study ID # CV185-640
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 20, 2017
Est. completion date January 29, 2021

Study information

Verified date April 2022
Source Bristol-Myers Squibb
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

A study based on a chart review of participants that presented with a sudden blood clot in the lung


Recruitment information / eligibility

Status Completed
Enrollment 660
Est. completion date January 29, 2021
Est. primary completion date January 29, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adults participants at date of admission - Primary presentation consistent with PE followed by objectively-confirmed acute PE - Received anti-coagulation upon diagnosis of PE during study period and in receipt of anti-coagulation at discharge Exclusion Criteria: - PE diagnosed during a hospital admission for a reason other than PE during the study period - Patients receiving anticoagulation at the time of presentation - Patients presenting outside the defined study period Other protocol defined inclusion/exclusion criteria could apply

Study Design


Intervention

Other:
Non-Interventional
Non-Interventional

Locations

Country Name City State
United Kingdom Local Institution Cardiff

Sponsors (1)

Lead Sponsor Collaborator
Bristol-Myers Squibb

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Compare the average length of stay in secondary care 60 days
Secondary Total length of stay, including repeat admissions During the first 30 days after presentation of PE
Secondary Distribution of clinical characteristics of patients admitted with a PE Clinical characteristics will be summarized using descriptive statistics Baseline
Secondary Distribution of demographic data of patients admitted with a PE Demographic data will be summarized using descriptive statistics Baseline
See also
  Status Clinical Trial Phase
Completed NCT01580085 - Obstructive Sleep Apnea in Pulmonary Embolism N/A
Enrolling by invitation NCT01558206 - Ultrasonography of Chest Versus Pulmonary Artery CT Angiography in Patients With Symptoms and Signs in Favor of PTE N/A
Completed NCT01513759 - Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy Phase 3
Completed NCT02616991 - Computed Tomography CT Venography During Postpartum Venous Thromboembolism N/A
Completed NCT00968929 - Recombinant Streptokinase Versus Urokinase in Pulmonary Embolism in China (RESUPEC) Phase 4
Not yet recruiting NCT06206967 - Promotion of Active Lifestyle in Thromboembolism Patients N/A
Recruiting NCT04405869 - Thromboembolic Events in Severe COVID-19 Patients
Completed NCT01206751 - Multi-detector Computer Tomography Protocol Project: Chest Imaging Technique and Case Presentation N/A